Biblio Discovery — Demo Discovery Service

10 hasil untuk "Kensei Taguchi"

Menampilkan 1–10 · 0,61 detik · RSS

  1. Artikel Jurnal

    RAGE signaling regulates the progression of diabetic complications

    Kensei Taguchi; Kei Fukami

    Frontiers in Pharmacology, Vol. 14 · 2023 · Inggris · DOAJ Scopus

    Diabetes, the ninth leading cause of death globally, is expected to affect 642 million people by 2040. With the advancement of an aging society, the number of patients with diabetes having multiple underlying diseases, such as hypertension, obesity, and chronic inflammation, is increasing. Thus…

  2. Artikel Jurnal Teks lengkap

    The impact of ischemic reperfusion injury on contralateral kidneys and the determinants of renal prognosis after robot-assisted partial nephrectomy

    Mitsunori Matsuo; Kensei Taguchi; Yunosuke Yokota dkk.

    PLOS ONE, Vol. 20 No. 4 · 2025 · Inggris · PLOS Scopus

    Robot-assisted laparoscopic partial nephrectomy (RAPN) is a safe and effective option for renal cell carcinoma (RCC). However, clamping of renal artery during RAPN sometimes causes ischemic reperfusion (IR) injury (IRI), which affects renal function at some later time. In the present study, we…

  3. Artikel Jurnal Teks lengkap

    Dysbiosis-Related Advanced Glycation Endproducts and Trimethylamine N-Oxide in Chronic Kidney Disease

    Kensei Taguchi; Kei Fukami; Bertha C. Elias dkk.

    Toxins, Vol. 13 No. 5 · 2021 · Inggris · DOAJ Scopus

    Chronic kidney disease (CKD) is a public health concern that affects approximately 10% of the global population. CKD is associated with poor outcomes due to high frequencies of comorbidities such as heart failure and cardiovascular disease. Uremic toxins are compounds that are usually filtered and…

  4. Artikel Jurnal Teks lengkap

    The Pathological Role of LDL in Membranous Nephropathy and Diabetic Nephropathy and the Protective Efficacy of LDL Apheresis: A Narrative Review

    Goh Kodama; Kensei Taguchi; Yusei Wada dkk.

    Toxins, Vol. 18 No. 1 · 2026 · Inggris · DOAJ Scopus

    Diabetic nephropathy (DN) is the leading cause of end-stage kidney disease worldwide. One-third of patients with DN develop primary glomerulonephritis, and membranous nephropathy (MN) is the most common concurrent glomerulonephritis. Nephrotic syndrome (NS) due to DN and MN is often refractory to…

  5. Artikel Jurnal

    Triple combination therapy with telmisartan, amlodipine, and hydrochlorothiazide ameliorates albuminuria in a normotensive rat remnant kidney model

    Sakuya Ito; Yosuke Nakayama; Goh Kodama dkk.

    Renal Replacement Therapy, Vol. 7 No. 1 · 2021 · Inggris · DOAJ Scopus

    Abstract Background Some types of antihypertensive drugs may have pleiotropic effects in patients with chronic kidney disease (CKD). However, whether triple combination therapy with angiotensin II receptor blockers (ARBs), calcium channel blockers (CCBs), and thiazide diuretics (TZD) confer…

  6. Artikel Jurnal

    Glucagon like peptide-1 modulates urinary sodium excretion in diabetic kidney disease via ENaC activation

    Goh Kodama; Kensei Taguchi; Sakuya Ito dkk.

    Scientific Reports, Vol. 15 No. 1 · 2025 · Inggris · DOAJ Scopus

    Abstract Diabetic kidney disease (DKD) is a leading cause of end stage kidney disease. Elevated salt sensitivity by epithelial sodium channel (ENaC) overexpression may be a residual risk factor for DKD. We found that combination therapy of linagliptin (LINA) to empagliflozin (EMPA), but not EMPA…

  7. Artikel Jurnal

    Cyclin G1 induces maladaptive proximal tubule cell dedifferentiation and renal fibrosis through CDK5 activation

    Kensei Taguchi; Bertha C. Elias; Sho Sugahara dkk.

    The Journal of Clinical Investigation, Vol. 132 No. 23 · 2022 · Inggris · DOAJ Scopus

    Acute kidney injury (AKI) occurs in approximately 13% of hospitalized patients and predisposes patients to chronic kidney disease (CKD) through the AKI-to-CKD transition. Studies from our laboratory and others have demonstrated that maladaptive repair of proximal tubule cells (PTCs), including…

  8. Artikel Jurnal

    Involvement of impaired carnitine-induced fatty acid oxidation in experimental and human diabetic kidney disease

    Sakuya Ito; Kensei Taguchi; Goh Kodama dkk.

    JCI Insight, Vol. 10 No. 13 · 2025 · Inggris · DOAJ Scopus

    Diabetic kidney disease (DKD) is the leading cause of end-stage kidney disease. Kidney tubular cells have a high energy demand, dependent on fatty acid oxidation (FAO). Although carnitine is indispensable for FAO, the pathological role of carnitine deficiency in DKD is not fully understood. We…